This pan-tumor signature defined by Ayers et al. contains IFN-γ- and T cell-associated inflammatory genes, and high expression of this gene signature correlated well with objective response to pembrolizumab (1-sided p-value < 0.001) [125]. Here, IFNG is linked to neoplasm.